作者:
Juliane L,Buhl [1]
;
Florian,Selt [2]
;
Thomas,Hielscher [3]
;
Romain,Guiho [1]
;
Jonas,Ecker [3]
;
Felix,Sahm [4]
;
Johannes,Ridinger [5]
;
Dennis,Riehl [6]
;
Diren,Usta [1]
;
Britta,Ismer [3]
;
Alexander C,Sommerkamp [4]
;
J P,Martinez-Barbera [7]
;
Annika K,Wefers [8]
;
Marc,Remke [1]
;
Daniel,Picard [2]
;
Stefan,Pusch [3]
;
Jan,Gronych [9]
;
Ina,Oehme [1]
;
Cornelis M,van Tilburg [3]
;
Marcel,Kool [1]
;
Daniela,Kuhn [2]
;
David,Capper [10]
;
Andreas,von Deimling [1]
;
Martin U,Schuhmann [2]
;
Christel,Herold-Mende [10]
;
Andrey,Korshunov [6]
;
Tilman,Brummer [7]
;
Stefan M,Pfister [8]
;
David T W,Jones [11]
;
Olaf,Witt [12]
;
Till,Milde [13]
作者单位:
Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
[1]
Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
[2]
Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
[3]
KiTZ Clinical Trial Unit (ZIPO), Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.
[4]
Division of Biostatistics, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
[5]
Developmental Biology and Cancer Programme, Birth Defects Research Centre, Great Ormond Street Institute of Child Health, University College London, London, UK.
[6]
Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.
[7]
Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
[8]
Immune Monitoring Unit, DKFZ/NCT, Heidelberg, Germany.
[9]
Pediatric Glioma Research Group, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
[10]
Department of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Consortium for Translational Cancer Research (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.
[11]
Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany.
[12]
Department of Neuropathology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
[13]
Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[14]
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
[15]
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Neuropathology, Berlin, Germany.
[16]
Division of Pediatric Neurosurgery, Department of Neurosurgery, University Hospital Tübingen, Tübingen, Germany.
[17]
Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.
[18]
Institute of Molecular Medicine and Cell Research (IMMZ), Faculty of Medicine, University of Freiburg, Freiburg, Germany, Centre for Biological Signalling Studies BIOSS, University of Freiburg and German Consortium for Translational Cancer Research (DKTK), Freiburg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[19]
Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany. t.milde@kitz-heidelberg.de.
[20]
DOI
10.1158/1078-0432.CCR-18-1965
PMID
30530705
发布时间
2024-02-10